shroomstreet.co valuation and analysis

Robots.txt Information
Robot Path Permission
GoogleBot /
BingBot /
BaiduSpider /
YandexBot /
Meta Tags
Title Psychedelic Chronicle • News, Research, Guides &
Description Psychedelic Chronicle provides the latest psychedelic news, research findings, informational guides & more from the world of
Keywords N/A
Server Information
WebSite shroomstreet faviconshroomstreet.co
Host IP 109.106.240.17
Location Serbia
Related Websites
Site Rank
More to Explore
shroomstreet.co Valuation
US$1,274
Last updated: 2022-10-06 12:59:31

shroomstreet.co has Semrush global rank of 0. shroomstreet.co has an estimated worth of US$ 1,274, based on its estimated Ads revenue. shroomstreet.co receives approximately 147 unique visitors each day. Its web server is located in Serbia, with IP address 109.106.240.17. According to SiteAdvisor, shroomstreet.co is safe to visit.

Traffic & Worth Estimates
Purchase/Sale Value US$1,274
Daily Ads Revenue US$1
Monthly Ads Revenue US$35
Yearly Ads Revenue US$423
Daily Unique Visitors 9
Note: All traffic and earnings values are estimates.
DNS Records
Host Type TTL Data
shroomstreet.co. A 14395 IP: 109.106.240.17
shroomstreet.co. NS 86400 NS Record: ns2.dns-parking.com.
shroomstreet.co. NS 86400 NS Record: ns1.dns-parking.com.
shroomstreet.co. MX 14400 MX Record: 5 mx1.hostinger.com.
shroomstreet.co. MX 14400 MX Record: 10 mx2.hostinger.com.
shroomstreet.co. TXT 14400 TXT Record: v=spf1 include:spf.titan.email include:spf.mx.hostinger.com include:relay.mailchannels.net ~all
HtmlToTextCheckTime:2022-10-06 12:59:31
Suggestions Psychedelic News DMT Ketamine Mescaline Psilocybin CEO INTERVIEWS Psychedelic News Tryp Therapeutics Add 2 New Provisional Patents to Intellectual Property Portfolio September 30, 2022 1 min read Recently, clinical-stage psychedelic biotechnology company Tryp Therapeutics Inc. (CSE: TRYP) (OTCQB: TRYPF) filed for two new provisional patents strengthening the company’s intellectual property portfolio. The company which focuses on developing psilocybin-based medicines for illnesses with unmet medical needs announced the 2 patents via press release. The first #63/405,786 is a patent application for the use of psilocybin to treat patients with fibromyalgia while the other patent, #63/375,305 expands the intellectual property related to the company’s development of TRP-8803. About Tryp Read More Psychedelic News Biomind Labs Complete Phase II Dosing of DMT-Based BMND01 for Treatment-Resistant Depression Leading psychedelic biotech company Biomind Labs Inc. (NEO: BMND) (OTC:
HTTP Headers
HTTP/1.1 301 Moved Permanently
Connection: Keep-Alive
Keep-Alive: timeout=5, max=100
x-powered-by: PHP/7.2.34
content-type: text/html; charset=UTF-8
x-ua-compatible: IE=edge
x-redirect-by: WordPress
location: https://shroomstreet.co/
date: Tue, 26 Oct 2021 01:00:49 GMT
server: LiteSpeed

HTTP/2 200 
x-powered-by: PHP/7.2.34
content-type: text/html; charset=UTF-8
x-ua-compatible: IE=edge
link: ; rel="https://api.w.org/"
link: ; rel="alternate"; type="application/json"
link: ; rel=shortlink
date: Tue, 26 Oct 2021 01:00:51 GMT
server: LiteSpeed
alt-svc: h3=":443"; ma=2592000, h3-29=":443"; ma=2592000, h3-Q050=":443"; ma=2592000, h3-Q046=":443"; ma=2592000, h3-Q043=":443"; ma=2592000, quic=":443"; ma=2592000; v="43,46"